JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

Search

Microbot Medical Inc

Затворен

2.65 -8.3

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.64

Максимум

2.96

Ключови измерители

By Trading Economics

Приходи

791K

-2.6M

Служители

20

EBITDA

-127K

-3.4M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+210.34% upside

Дивиденти

By Dow Jones

Следващи печалби

12.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

23M

115M

Предишно отваряне

10.95

Предишно затваряне

2.65

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.07.2025 г., 23:57 ч. UTC

Придобивния, сливания и поглъщания

EQT: To Spend Y407.82B for Tender Offer

29.07.2025 г., 23:56 ч. UTC

Придобивния, сливания и поглъщания

EQT: Tender Offer Price Is Y5,700 a Share

29.07.2025 г., 23:54 ч. UTC

Придобивния, сливания и поглъщания

EQT To Start Tender Offer for Fujitec

29.07.2025 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29.07.2025 г., 23:36 ч. UTC

Пазарно говорене

Gold Steady Ahead of FOMC Decision -- Market Talk

29.07.2025 г., 22:57 ч. UTC

Пазарно говорене

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29.07.2025 г., 22:50 ч. UTC

Пазарно говорене

Mondelez Warns of Price Increases in North America -- Market Talk

29.07.2025 г., 22:44 ч. UTC

Придобивния, сливания и поглъщания

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29.07.2025 г., 22:41 ч. UTC

Придобивния, сливания и поглъщания

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29.07.2025 г., 22:41 ч. UTC

Придобивния, сливания и поглъщания

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29.07.2025 г., 22:35 ч. UTC

Печалби

IGO Maintains Nova Life of Mine Production Guidance

29.07.2025 г., 22:35 ч. UTC

Печалби

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29.07.2025 г., 22:35 ч. UTC

Печалби

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29.07.2025 г., 22:34 ч. UTC

Печалби

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29.07.2025 г., 22:34 ч. UTC

Печалби

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29.07.2025 г., 22:34 ч. UTC

Пазарно говорене
Печалби

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29.07.2025 г., 22:33 ч. UTC

Печалби

IGO Had A$279.7 Million of Cash at End-June

29.07.2025 г., 22:33 ч. UTC

Печалби

IGO 4Q Underlying Free Cash A$2.4 Million

29.07.2025 г., 22:33 ч. UTC

Печалби

IGO FY Sales Revenue A$512.5 Million

29.07.2025 г., 22:33 ч. UTC

Печалби

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29.07.2025 г., 22:32 ч. UTC

Печалби

IGO FY Nickel Production 17,173 Tons

29.07.2025 г., 22:32 ч. UTC

Печалби

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29.07.2025 г., 22:32 ч. UTC

Печалби

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29.07.2025 г., 22:31 ч. UTC

Пазарно говорене
Печалби

Global Equities Roundup: Market Talk

29.07.2025 г., 22:31 ч. UTC

Пазарно говорене
Печалби

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29.07.2025 г., 22:31 ч. UTC

Печалби

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29.07.2025 г., 22:31 ч. UTC

Печалби

IGO FY Spodumene Production 1.48 Million Tons

29.07.2025 г., 22:30 ч. UTC

Печалби

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29.07.2025 г., 22:30 ч. UTC

Печалби

IGO 4Q Underlying Ebitda A$62 Million

29.07.2025 г., 22:22 ч. UTC

Печалби

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

210.34% нагоре

12-месечна прогноза

Среден 9 USD  210.34%

Висок 9 USD

Нисък 9 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

Краткосрочен план

Neutral Evidence

Средносрочен план

Very Strong Bullish Evidence

Дългосрочен план

Weak Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.